Proactive Investors - Run By Investors For Investors

ICC International Cannabis agrees to buy Green Gene Research in stock deal

The buyer will issue 10 million common shares for the target company's proprietary strain portfolio, seed inventory and clone catalog
Marijuana plants in a greenhouse
ICC has agreed to buy a company with a portfolio of more than 120 lab-tested cannabis strains

ICC International Cannabis Corp (CNSX:WRLD) said Tuesday that it has agreed to buy Green Gene Research Inc, a company with a portfolio of more than 120 lab-tested Cannabis strains.

Under the agreement, Vancouver-based ICC said it will issue 10 million common shares, with a finder’s fee payable. Green Gene will transfer ownership of its proprietary strain portfolio, seed inventory and clone catalog to ICC.

READ: ICC International Cannabis clears Colombia cannabis agricultural inspection

ICC plans to deploy Green Gene’s genetic strains at its operations in Colombia, Denmark, Poland, Greece, Portugal, South Africa and Lesotho. In addition, the company has a distribution network of 35,000 pharmacies in 16 countries.

The buyer said it expects the deal to help it draw revenue from licensing of premium genetic strains, wholesale seed sales, clone fulfillment services, custom breeding, tissue culture and strain patenting services.

“The acquisition of Green Gene broadens the product offering that ICC can provide to its clients and to its distribution network,” ICC CEO Eugene Beukman said in a press release statement.

Shares of ICC slipped 4.08$ to C$0.47 in Canada on Monday.

Last week, the company said it cleared an inspection of its products by Colombian agricultural authorities.

Contact Dennis Fitzgerald at [email protected]

 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full WRLD.U profile View Profile

ICC International Cannabis Corp. Timeline

Related Articles

A WeedMD greenhouse
January 21 2019
WeedMD produces cannabis and cannabis oil for both the medical and adult-use markets
1541165310_canadian-flag-1.jpg
November 02 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement
data graphic
Fri
The Toronto company is busy meeting what it says is significant demand by building a data asset covering the medical cannabis sector
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use